Guardant Health, Inc. Quarterly Selling and Marketing Expense in USD from Q3 2017 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary: Guardant Health, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from Q3 2017 to Q2 2024.
Guardant Health, Inc. Selling and Marketing Expense for the quarter ending June 30, 2024 was $81.9M, a 15.2% increase year-over-year.
Guardant Health, Inc. Selling and Marketing Expense for the twelve months ending June 30, 2024 was $310M, a 0.45% increase year-over-year.
Guardant Health, Inc. annual Selling and Marketing Expense for 2023 was $295M, a 1.54% decline from 2022.
Guardant Health, Inc. annual Selling and Marketing Expense for 2022 was $300M, a 56.3% increase from 2021.
Guardant Health, Inc. annual Selling and Marketing Expense for 2021 was $192M, a 80.1% increase from 2020.

Selling and Marketing Expense, Trailing 12 Months (USD)

Selling and Marketing Expense, Quarterly (USD)

Selling and Marketing Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	$310M	$81.9M	+$10.8M	+15.2%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-07
Q1 2024	$300M	$80.4M	+$4.3M	+5.65%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$295M	$79.1M	-$2.3M	-2.82%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-22
Q3 2023	$298M	$68.9M	-$11.4M	-14.2%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-06
Q2 2023	$309M	$71M	-$2.56M	-3.48%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-07
Q1 2023	$312M	$76.1M	+$11.7M	+18.1%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-09
Q4 2022	$300M	$81.4M	+$21.8M	+36.6%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-22
Q3 2022	$278M	$80.4M	+$30.1M	+60%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-06
Q2 2022	$248M	$73.6M	+$25.9M	+54.3%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-03
Q1 2022	$222M	$64.4M	+$30.1M	+87.6%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-09
Q4 2021	$192M	$59.6M	+$28.3M	+90.5%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-22
Q3 2021	$164M	$50.2M	+$25.1M	+100%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-03
Q2 2021	$138M	$47.7M	+$22.7M	+90.8%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-04
Q1 2021	$116M	$34.3M	+$9.22M	+36.7%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-05
Q4 2020	$107M	$31.3M	+$9M	+40.4%	Oct 1, 2020	Dec 31, 2020	10-K	2023-02-23
Q3 2020	$97.5M	$25.1M	+$6.29M	+33.5%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-04
Q2 2020	$91.2M	$25M	+$5.58M	+28.7%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-05
Q1 2020	$85.6M	$25.1M	+$7.31M	+41%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-06
Q4 2019	$78.3M	$22.3M	+$5.17M	+30.2%	Oct 1, 2019	Dec 31, 2019	10-K	2022-02-24
Q3 2019	$73.2M	$18.8M	+$5.34M	+39.6%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-05
Q2 2019	$67.8M	$19.4M	+$7.86M	+67.9%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-06
Q1 2019	$60M	$17.8M	+$6.5M	+57.4%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-07
Q4 2018	$53.5M	$17.1M			Oct 1, 2018	Dec 31, 2018	10-K	2021-02-25
Q3 2018		$13.5M	+$5.66M	+72.4%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-07
Q2 2018		$11.6M			Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-07
Q1 2018		$11.3M			Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-10
Q3 2017		$7.81M			Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-19

* An asterisk sign (*) next to the value indicates that the value is likely invalid.